• Fri, August 20, 2021
  • Mon, August 23, 2021
  • Tue, August 24, 2021

Aydin Huseynov Initiated (ATHE) at Buy and Held Target at $40 on, Aug 20th, 2021

Aydin Huseynov of Benchmark, Initiated "Alterity Therapeutics Limited" (ATHE) at Buy and Held Target at $40 on, Aug 20th, 2021.

Aydin, nor any peers, have made any analyst calls on ATHE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍